CONMED Net Worth 2010-2023 | CNMD

Interactive chart of historical net worth (market cap) for CONMED (CNMD) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. CONMED net worth as of April 22, 2024 is $2.24B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.236B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
West Pharmaceutical Services (WST) United States $27.478B 46.45
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
Henry Schein (HSIC) United States $9.256B 16.01
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
STAAR Surgical (STAA) United States $2.275B 71.61
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72
Biolase (BIOL) United States $0.005B 0.00